High-dose intensity regimens with epirubicin in ovarian cancer.
Vermorken
J B
JB
Department of Oncology, Free University Hospital, Amsterdam, The Netherlands.
Bolis
G
G
van Rijswijk
R E
RE
Kobierska
A
A
Chevallier
B
B
van der Burg
M E
ME
Zanaboni
F
F
Lentz
M A
MA
Burger
C W
CW
Kenemans
P
P
D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D015251:Epirubicin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D015251:Epirubicin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D002945:Cisplatin